DANIELLE ELBERT: Open Payments
NPI 1336768357 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,493 in 95 payments from 17 companies in 2025. Trend: 2023 $1,936 · 2024 $2,501 · 2025 $2,493
Food & beverage: $2,181Education: $311
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $306 |
| Janssen Biotech, Inc. | 9 | $295 |
| GENZYME CORPORATION | 10 | $272 |
| Regeneron Healthcare Solutions, Inc. | 8 | $247 |
| LEO Pharma Inc. | 10 | $226 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $194 |
| Arcutis Biotherapeutics, Inc. | 3 | $171 |
| ABBVIE INC. | 9 | $159 |
| Amgen Inc. | 7 | $157 |
| Lilly USA, LLC | 4 | $117 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Zoryve, Otezla, SKYRIZI, ADBRY, OPZELURA.
Industry payments across GA — which companies pay providers there.
